<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Juarez-Fernandez M</submitter><funding>Junta de Castilla y León cofunded by the European Social Fund</funding><funding>Departamento de Industria del Gobierno Vasco</funding><funding>Ayudas Ramón y Cajal de la Agencia Estatal de Investigación</funding><funding>Ministerio de Ciencia, Innovación y Universidades MICINN integrado en el Plan Estatal de Investigación Científica y Técnica y de Innovación, cofinanciado con Fondos FEDER</funding><funding>Junta de Castilla y León</funding><funding>Ministerio de Economía y Competitividad/FEDER</funding><funding>Proyecto Desarrollo Tecnologico CIBERehd</funding><funding>BIOEF (Basque Foundation for Innovation and Health Research)</funding><funding>Instituto de Salud Carlos III, Proyectos de Investigación en Salud</funding><funding>Junta de Castilla y León (FEDER)</funding><funding>Ministerio de Ciencia e Innovación, Programa Retos-Colaboración</funding><funding>Fundación Científica de la Asociación Española Contra el Cancer (AECC Scientific Foundation) Rare Tumor Calls 2017</funding><funding>Ministerio de Ciencia, Innovación y Universidades</funding><funding>Asociación Española contra el Cáncer</funding><funding>Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa</funding><funding>Ministerio de Economía y Competitividad</funding><funding>La Caixa Foundation Program</funding><pagination>1654-1669</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10113004</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>77(5)</volume><pubmed_abstract>&lt;h4>Background and aims&lt;/h4>Recent studies suggest that mitochondrial dysfunction promotes progression to NASH by aggravating the gut-liver status. However, the underlying mechanism remains unclear. Herein, we hypothesized that enhanced mitochondrial activity might reshape a specific microbiota signature that, when transferred to germ-free (GF) mice, could delay NASH progression.&lt;h4>Approach and results&lt;/h4>Wild-type and methylation-controlled J protein knockout (MCJ-KO) mice were fed for 6 weeks with either control or a choline-deficient, L-amino acid-defined, high-fat diet (CDA-HFD). One mouse of each group acted as a donor of cecal microbiota to GF mice, who also underwent the CDA-HFD model for 3 weeks. Hepatic injury, intestinal barrier, gut microbiome, and the associated fecal metabol</pubmed_abstract><journal>Hepatology (Baltimore, Md.)</journal><pubmed_title>Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression.</pubmed_title><pmcid>PMC10113004</pmcid><funding_grant_id>PID2020-120363RB-I0</funding_grant_id><funding_grant_id>DTS20/00138</funding_grant_id><funding_grant_id>LE063U16</funding_grant_id><funding_grant_id>BFU2017-87960-R</funding_grant_id><funding_grant_id>GRS2126/A/2020</funding_grant_id><funding_grant_id>PID2020‐120363RB‐I0</funding_grant_id><funding_grant_id>FPU18/06257</funding_grant_id><funding_grant_id>LE017P20</funding_grant_id><funding_grant_id>RTC2019-007125-1</funding_grant_id><funding_grant_id>PID2020-117116RB-I00</funding_grant_id><funding_grant_id>BFU2017‐87960‐R</funding_grant_id><funding_grant_id>RY2013-13666</funding_grant_id><pubmed_authors>Delgado TC</pubmed_authors><pubmed_authors>Rodriguez H</pubmed_authors><pubmed_authors>Bravo M</pubmed_authors><pubmed_authors>Simon J</pubmed_authors><pubmed_authors>Lorenzo O</pubmed_authors><pubmed_authors>Garcia-Mediavilla MV</pubmed_authors><pubmed_authors>Lachiondo-Ortega S</pubmed_authors><pubmed_authors>Serrano-Macia M</pubmed_authors><pubmed_authors>Anguita J</pubmed_authors><pubmed_authors>Abecia L</pubmed_authors><pubmed_authors>Juarez-Fernandez M</pubmed_authors><pubmed_authors>Rincon M</pubmed_authors><pubmed_authors>Martinez-Chantar ML</pubmed_authors><pubmed_authors>Sanchez-Campos S</pubmed_authors><pubmed_authors>Martinez-Florez S</pubmed_authors><pubmed_authors>Goikoetxea-Usandizaga N</pubmed_authors><pubmed_authors>Porras D</pubmed_authors><pubmed_authors>Varela-Rey M</pubmed_authors><pubmed_authors>Nistal E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression.</name><description>&lt;h4>Background and aims&lt;/h4>Recent studies suggest that mitochondrial dysfunction promotes progression to NASH by aggravating the gut-liver status. However, the underlying mechanism remains unclear. Herein, we hypothesized that enhanced mitochondrial activity might reshape a specific microbiota signature that, when transferred to germ-free (GF) mice, could delay NASH progression.&lt;h4>Approach and results&lt;/h4>Wild-type and methylation-controlled J protein knockout (MCJ-KO) mice were fed for 6 weeks with either control or a choline-deficient, L-amino acid-defined, high-fat diet (CDA-HFD). One mouse of each group acted as a donor of cecal microbiota to GF mice, who also underwent the CDA-HFD model for 3 weeks. Hepatic injury, intestinal barrier, gut microbiome, and the associated fecal metabol</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 May</publication><modification>2025-04-04T08:28:54.988Z</modification><creation>2025-04-04T08:28:54.988Z</creation></dates><accession>S-EPMC10113004</accession><cross_references><pubmed>35921199</pubmed><doi>10.1002/hep.32705</doi></cross_references></HashMap>